Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118131925 | 11813192 | 5 | F | 201508 | 20160906 | 20151209 | 20160915 | EXP | GB-MHRA-EYC 00130145 | GB-DRREDDYS-GER/UKI/15/0054474 | DR REDDYS | 31.00 | YR | M | Y | 75.00000 | KG | 20160915 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118131925 | 11813192 | 1 | PS | FINASTERIDE. | FINASTERIDE | 1 | Oral | U | UNKNOWN | 76436 | 1 | MG | TABLET | QD | |||||
| 118131925 | 11813192 | 2 | SS | PROPECIA | FINASTERIDE | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 118131925 | 11813192 | 3 | C | MINOXIDIL. | MINOXIDIL | 1 | Topical | 0 | |||||||||||
| 118131925 | 11813192 | 4 | C | ZOPICLONE | ZOPICLONE | 1 | 0 | 3.75 | MG | TABLET | |||||||||
| 118131925 | 11813192 | 5 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 118131925 | 11813192 | 6 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 118131925 | 11813192 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 118131925 | 11813192 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118131925 | 11813192 | 1 | Androgenetic alopecia |
| 118131925 | 11813192 | 2 | Androgenetic alopecia |
| 118131925 | 11813192 | 3 | Product used for unknown indication |
| 118131925 | 11813192 | 4 | Product used for unknown indication |
| 118131925 | 11813192 | 5 | Product used for unknown indication |
| 118131925 | 11813192 | 6 | Product used for unknown indication |
| 118131925 | 11813192 | 7 | Product used for unknown indication |
| 118131925 | 11813192 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118131925 | 11813192 | DE |
| 118131925 | 11813192 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118131925 | 11813192 | Anxiety | |
| 118131925 | 11813192 | Blood testosterone decreased | |
| 118131925 | 11813192 | Completed suicide | |
| 118131925 | 11813192 | Depression | |
| 118131925 | 11813192 | Headache | |
| 118131925 | 11813192 | Hypertension | |
| 118131925 | 11813192 | Insomnia | |
| 118131925 | 11813192 | Nausea | |
| 118131925 | 11813192 | Palpitations | |
| 118131925 | 11813192 | Panic attack | |
| 118131925 | 11813192 | Suicidal ideation | |
| 118131925 | 11813192 | Testicular pain | |
| 118131925 | 11813192 | Thinking abnormal | |
| 118131925 | 11813192 | Vomiting | |
| 118131925 | 11813192 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118131925 | 11813192 | 1 | 200907 | 201107 | 0 | |
| 118131925 | 11813192 | 2 | 201404 | 20150720 | 0 | |
| 118131925 | 11813192 | 3 | 201505 | 0 | ||
| 118131925 | 11813192 | 4 | 20150821 | 0 | ||
| 118131925 | 11813192 | 7 | 20151013 | 0 | ||
| 118131925 | 11813192 | 8 | 20151030 | 0 |